Vancouver, British Columbia–(Newsfile Corp. – February 10, 2021) – NeonMind Biosciences Inc. (CSE: NEON) (FSE: 6UF) (“NeonMind“), announces that through its consumer products division, it submitted on February 2, 2021 four applications to Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD), to obtain product licenses for its products with 100% plant-based extracts…
